Literature DB >> 24484781

What, if all alerts were specific - estimating the potential impact on drug interaction alert burden.

Hanna M Seidling1, Ulrike Klein2, Matthias Schaier3, David Czock4, Dirk Theile4, Markus G Pruszydlo4, Jens Kaltschmidt4, Gerd Mikus4, Walter E Haefeli5.   

Abstract

PURPOSE: Clinical decision support systems (CDSS) may potentially improve prescribing quality, but are subject to poor user acceptance. Reasons for alert overriding have been identified and counterstrategies have been suggested; however, poor alert specificity, a prominent reason of alert overriding, has not been well addressed. This paper aims at structuring modulators that determine alert specificity and estimating their quantitative impact on alert burden.
METHODS: We developed and summarized optimizing strategies to guarantee the specificity of alerts and applied them to a set of 100 critical and frequent drug interaction (DDI) alerts. Hence, DDI alerts were classified as dynamic, i.e. potentially sensitive to prescription-, co-medication-, or patient-related factors that would change alert severity or render the alert inappropriate compared to static, i.e. always applicable alerts not modulated by cofactors.
RESULTS: Within the subset of 100 critical DDI alerts, only 10 alerts were considered as static and for 7 alerts, relevant factors are not generally available in today's patient charts or their consideration would not impact alert severity. The vast majority, i.e. 83 alerts, might require a decrease in alert severity due to factors related to the prescription (N=13), the co-medication (N=11), individual patient data (N=36), or combinations of them (N=23). Patient-related factors consisted mainly of three lab values, i.e. renal function, potassium, and therapeutic drug monitoring results.
CONCLUSION: This paper outlines how promising the refinement of knowledge bases is in order to increase specificity and decrease alert burden and suggests how to structure knowledge bases to refine DDI alerting.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alert fatigue; Alert specificity; Clinical decision support systems; Drug–drug interactions

Mesh:

Year:  2014        PMID: 24484781     DOI: 10.1016/j.ijmedinf.2013.12.006

Source DB:  PubMed          Journal:  Int J Med Inform        ISSN: 1386-5056            Impact factor:   4.046


  27 in total

1.  Potential drug-related problems detected by electronic expert support system: physicians' views on clinical relevance.

Authors:  Tora Hammar; Bodil Lidström; Göran Petersson; Yngve Gustafson; Birgit Eiermann
Journal:  Int J Clin Pharm       Date:  2015-06-06

2.  Capsule Commentary on Shelton et al., Reducing PSA-Based Prostate Cancer Screening in Men ≥ 75 Years Old with Highly Specific Computerized Clinical Decision Support.

Authors:  Sarah Patricia Slight
Journal:  J Gen Intern Med       Date:  2015-08       Impact factor: 5.128

3.  The Future CPOE Workflow: Augmenting Clinical Decision Support With Pharmacist Expertise.

Authors:  John A Dougherty; Mark Bonfiglio
Journal:  Hosp Pharm       Date:  2018-08-03

4.  Evaluation of Clinical Relevance of Drug-Drug Interaction Alerts Prior to Implementation.

Authors:  S M M Meslin; W Y Zheng; R O Day; E M Y Tay; M T Baysari
Journal:  Appl Clin Inform       Date:  2018-11-28       Impact factor: 2.342

5.  Investigating the Additive Interaction of QT-Prolonging Drugs in Older People Using Claims Data.

Authors:  Andreas D Meid; Anna von Medem; Dirk Heider; Jürgen-Bernhard Adler; Christian Günster; Hanna M Seidling; Renate Quinzler; Hans-Helmut König; Walter E Haefeli
Journal:  Drug Saf       Date:  2017-02       Impact factor: 5.606

6.  Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support.

Authors:  Richard T Scheife; Lisa E Hines; Richard D Boyce; Sophie P Chung; Jeremiah D Momper; Christine D Sommer; Darrell R Abernethy; John R Horn; Stephen J Sklar; Samantha K Wong; Gretchen Jones; Mary L Brown; Amy J Grizzle; Susan Comes; Tricia Lee Wilkins; Clarissa Borst; Michael A Wittie; Daniel C Malone
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

7.  The potential for leveraging machine learning to filter medication alerts.

Authors:  Siru Liu; Kensaku Kawamoto; Guilherme Del Fiol; Charlene Weir; Daniel C Malone; Thomas J Reese; Keaton Morgan; David ElHalta; Samir Abdelrahman
Journal:  J Am Med Inform Assoc       Date:  2022-04-13       Impact factor: 4.497

8.  Clinician Perceptions of Timing and Presentation of Drug-Drug Interaction Alerts.

Authors:  Kate E Humphrey; Maria Mirica; Shobha Phansalkar; Al Ozonoff; Marvin B Harper
Journal:  Appl Clin Inform       Date:  2020-07-22       Impact factor: 2.342

9.  Using the Causal Inference Framework to Support Individualized Drug Treatment Decisions Based on Observational Healthcare Data.

Authors:  Andreas D Meid; Carmen Ruff; Lucas Wirbka; Felicitas Stoll; Hanna M Seidling; Andreas Groll; Walter E Haefeli
Journal:  Clin Epidemiol       Date:  2020-11-02       Impact factor: 4.790

10.  Recommendations for selecting drug-drug interactions for clinical decision support.

Authors:  Hugh Tilson; Lisa E Hines; Gerald McEvoy; David M Weinstein; Philip D Hansten; Karl Matuszewski; Marianne le Comte; Stefanie Higby-Baker; Joseph T Hanlon; Lynn Pezzullo; Kathleen Vieson; Amy L Helwig; Shiew-Mei Huang; Anthony Perre; David W Bates; John Poikonen; Michael A Wittie; Amy J Grizzle; Mary Brown; Daniel C Malone
Journal:  Am J Health Syst Pharm       Date:  2016-04-15       Impact factor: 2.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.